Non-cognate  	Non-cognate  	 JJ	B-NP
bystander  	bystander  	 JJ	I-NP
cytolysis  	cytolysis  	 NN	I-NP
by  	by  	 IN	O
clonal  	clonal  	 JJ	B-NP
epitope-specific  	epitope-specific  	 JJ	I-NP
CTL  	CTL  	 NN	I-NP
lines  	lines  	 NNS	I-NP
through  	through  	 IN	O
CD28-CD80  	CD28-CD80  	 CD	B-NP
interaction  	interaction  	 CD	I-NP
inhibits  	inhibits  	 JJ	O
antibody  	antibody  	 NN	B-NP
production 	production 	 NN	I-NP
:  	:  	 :	O
A  	A  	 DT	O
potential  	potential  	 JJ	B-NP
caveat  	caveat  	 NN	I-NP
to  	to  	 TO	O
CD8  	CD8  	 CD	B-NP
T-cell  	T-cell  	 JJ	I-NP
immunotherapy  	immunotherapy  	 JJ	I-NP
Adoptive  	Adoptive  	 JJ	I-NP
transfer  	transfer  	 NN	I-NP
of  	of  	 IN	I-NP
virus  	virus  	 NN	I-NP
epitope-specific  	epitope-specific  	 JJ	I-NP
CD8  	CD8  	 CD	I-NP
T  	T  	 NN	I-NP
cells  	cells  	 NNS	I-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
immunotherapy  	immunotherapy  	 JJ	B-NP
option  	option  	 NN	I-NP
to  	to  	 TO	O
control  	control  	 VB	O
cytomegalovirus  	cytomegalovirus  	 NNS	B-NP
( 	( 	 -LRB-	O
CMV 	CMV 	 NNP	B-NP
)  	)  	 -RRB-	O
infection  	infection  	 NN	B-NP
and  	and  	 CC	O
prevent  	prevent  	 VB	O
CMV  	CMV  	 JJ	B-NP
organ  	organ  	 NN	I-NP
disease  	disease  	 NN	I-NP
in  	in  	 IN	O
immunocompromised  	immunocompromised  	 JJ	B-NP
solid  	solid  	 JJ	I-NP
organ  	organ  	 NN	I-NP
transplantation  	transplantation  	 NN	I-NP
( 	( 	 -LRB-	O
SOT 	SOT 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
hematopoietic  	hematopoietic  	 JJ	B-NP
cell  	cell  	 NN	I-NP
transplantation  	transplantation  	 NN	I-NP
( 	( 	 -LRB-	O
HCT 	HCT 	 NNP	B-NP
)  	)  	 -RRB-	O
recipients 	recipients 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
therapy  	therapy  	 NN	O
aims  	aims  	 VBZ	O
at  	at  	 IN	O
an  	an  	 DT	O
early 	early 	 JJ	O
,  	,  	 ,	O
selective  	selective  	 JJ	B-NP
recognition  	recognition  	 NN	I-NP
and  	and  	 CC	O
cytolysis  	cytolysis  	 NN	B-NP
of  	of  	 IN	O
infected  	infected  	 JJ	O
cells  	cells  	 NNS	O
for  	for  	 IN	O
preventing  	preventing  	 VBG	O
viral  	viral  	 JJ	B-NP
spread  	spread  	 NN	I-NP
in  	in  	 IN	O
tissues  	tissues  	 NNS	O
with  	with  	 IN	O
no  	no  	 DT	O
adverse  	adverse  	 JJ	O
immunopathogenic  	immunopathogenic  	 JJ	B-NP
side-effects  	side-effects  	 NN	I-NP
by  	by  	 IN	O
attack  	attack  	 NN	O
of  	of  	 IN	O
uninfected  	uninfected  	 JJ	B-NP
bystander  	bystander  	 JJ	I-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
Here  	Here  	 RB	O
we  	we  	 PRP	O
describe  	describe  	 VBP	O
that  	that  	 DT	O
virus  	virus  	 NN	B-NP
epitope-specific 	epitope-specific 	 NN	I-NP
,  	,  	 ,	O
cloned  	cloned  	 VBN	B-NP
T-cell  	T-cell  	 JJ	I-NP
lines  	lines  	 NNS	I-NP
lyse  	lyse  	 JJ	I-NP
target  	target  	 NN	I-NP
cells  	cells  	 NNS	I-NP
that  	that  	 WDT	O
present  	present  	 VBP	O
the  	the  	 DT	O
cognate  	cognate  	 JJ	O
antigenic  	antigenic  	 JJ	B-NP
peptide  	peptide  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
TCR 	TCR 	 NNP	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
simultaneously  	simultaneously  	 RB	O
have  	have  	 VB	O
the  	the  	 DT	O
potential  	potential  	 JJ	O
to  	to  	 TO	O
lyse  	lyse  	 VB	O
uninfected  	uninfected  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
expressing  	expressing  	 VBG	O
the  	the  	 DT	O
CD28  	CD28  	 FW	B-NP
ligand  	ligand  	 FW	I-NP
CD80  	CD80  	 FW	I-NP
( 	( 	 -LRB-	O
B7-1 	B7-1 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
While  	While  	 IN	O
TCR-mediated  	TCR-mediated  	 JJ	B-NP
cytolysis  	cytolysis  	 NN	I-NP
requires  	requires  	 VBZ	O
co-receptor  	co-receptor  	 JJ	B-NP
CD8  	CD8  	 NN	I-NP
and  	and  	 CC	O
depends  	depends  	 VBZ	O
on  	on  	 IN	O
perforin 	perforin 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
TCR-independent  	TCR-independent  	 JJ	B-NP
and  	and  	 CC	O
viral  	viral  	 JJ	B-NP
epitope-independent  	epitope-independent  	 JJ	I-NP
cytolysis  	cytolysis  	 NN	I-NP
through  	through  	 IN	O
CD28-CD80  	CD28-CD80  	 CD	B-NP
signaling  	signaling  	 NN	I-NP
does  	does  	 VBZ	O
not  	not  	 RB	O
require  	require  	 VB	O
CD8  	CD8  	 CD	B-NP
on  	on  	 IN	O
the  	the  	 DT	O
effector  	effector  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
and  	and  	 CC	O
is  	is  	 VBZ	O
perforin-independent 	perforin-independent 	 JJ	B-NP
.  	.  	 .	O
Importantly 	Importantly 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
non-cognate  	non-cognate  	 JJ	B-NP
cytolysis  	cytolysis  	 JJ	I-NP
pathway  	pathway  	 NN	I-NP
leads  	leads  	 VBZ	O
to  	to  	 TO	O
bystander  	bystander  	 VB	O
cytolysis  	cytolysis  	 VBN	O
of  	of  	 IN	O
CD80-expressing  	CD80-expressing  	 CD	B-NP
B-cell  	B-cell  	 JJ	I-NP
blasts  	blasts  	 NNS	I-NP
and  	and  	 CC	O
thereby  	thereby  	 RB	O
inhibits  	inhibits  	 JJ	O
pan-specific  	pan-specific  	 JJ	B-NP
antibody  	antibody  	 NN	I-NP
production 	production 	 NN	I-NP
.  	.  	 .	O
